Welcome to LookChem.com Sign In|Join Free
  • or
4-(isonicotinoylamido)benzoic acid is an organic compound with the chemical formula C13H10N2O3. It is a white crystalline solid that is soluble in water and various organic solvents. 4-(ISONICOTINOYLAMINO)BENZOIC ACID is formed by the amide linkage between isonicotinoyl chloride and 4-aminobenzoic acid, resulting in a structure that features a benzoic acid group and an isonicotinamide group. It is used as an intermediate in the synthesis of pharmaceuticals and other chemical products, particularly in the preparation of certain anti-tuberculosis drugs. The compound's properties, such as its reactivity and solubility, make it a valuable building block in the development of new medications and other chemical applications.

5651-66-1

Post Buying Request

5651-66-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5651-66-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 5651-66-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,6,5 and 1 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 5651-66:
(6*5)+(5*6)+(4*5)+(3*1)+(2*6)+(1*6)=101
101 % 10 = 1
So 5651-66-1 is a valid CAS Registry Number.

5651-66-1Downstream Products

5651-66-1Relevant academic research and scientific papers

Synthetic and Biological Studies on New Urea and Triazole Containing Cystobactamid Derivatives

Cirnski, Katarina,Herrmann, Jennifer,Kirschning, Andreas,Müller, Rolf,Planke, Therese

supporting information, (2020/03/16)

Cystobactamids belong to the group of arene-based oligoamides that effectively inhibit bacterial type IIa topoisomerases. Cystobactamid 861-2 is the most active member of these antibiotics. Most amide bonds present in the cystobactamids link benzoic acids

TRICYCLIC THIENO-AZEPINE VASOPRESSIN ANTAGONISTS

-

, (2008/06/13)

This invention relates to new bicyclic non-peptide vasopressin antagonists which are useful in treating conditions where decreased vasopressin levels are desired, such as in congestive heart failure, in disease conditions with excess renal water reabsorption and in conditions with increased vascular resistance and coronary vasoconstriction.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 5651-66-1